Trial intelligence / Profile preview

Evaluation of Statin Therapy – Safety, Effect and Toxicity Mechanisms

2006-004686-34Phase 4Completed

Sponsor
Karolinska University Hospital
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of simvastatin, atorvastatin, fluvastatin and pravastatin in lipid disorder (4 arms), sponsored by Karolinska University Hospital. Primary endpoints: Frequency of muscle-related adverse drug reactions and Frequency of other adverse drug reactions. Started Jan 2007; status: completed.

02

Drugs

simvastatinatorvastatinfluvastatinpravastatin
03

Conditions

lipid disorder

Beyond the preview

Go deeper on 2006-004686-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004686-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call